When compared with the unpaired metformin group (Figure 2S), increased incidence risks of pancreatitis, gastric ulcer, acute nephritis, renal failure, thyroid cancer/dysfunction, and acne were evident in both short‐term and/or long‐term usage of GLP‐1 RAs. Here, GLP1R is linked to kidney failure.